Company / Total Debt
Bio-Rad Laboratories Total Debt History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$1.2B
FY2025
5-year range
$1.2B / $1.2B
FY2022-FY2025
Trend
+0.2%
vs FY2024
Sector context
#50 of 100
Health Care
What the data says
At $1.2B, Bio-Rad Laboratories's total debt ranks #51 of 100 in the Health Care sector. Total Debt remained relatively stable over the past 4 years, with values between $1.2B and $1.2B.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 3-year CAGR of +0.1%.
Remained stable around $1.2B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +0.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#51 of 100 in Health CareTop 50% of 100This company $1.2B Sector average $4.6B
▼
-73.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +0.1%, indicating consistent growth.
- In FY2025, total debt increased 0.2% year-over-year.
- Ranks #50 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +0.2% |
| FY2024 | $1.2B | -0.8% |
| FY2023 | $1.2B | +1.0% |
| FY2022 | $1.2B | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026